Biotech stock Crispr Therapeutics Inc's (NASDAQ:CRSP) recent rally seems to be losing steam as the shares are on track to end a seven-day winning streak, slipping 0.6% to $42.69. After…

Subscribe Now for Real-time Updates on the Latest Stories!
Tech stocks, however, took a hit as Nvidia (NVDA) fell nearly 4% midday. Wall Street analysts pointed to the AI…
The demand for leveraged and inverse exchange-traded funds (ETFs) is on the rise amidst market volatility, according to Direxion CEO…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…
The New York Times on Immigration: A Critical Analysis The recent article in New York Times delves into the complex…
Investors pulled over $1 billion from spot Bitcoin exchange-traded funds on Tuesday, marking the largest one-day outflow since these funds…
The Importance of Friedrich Hayek's "The Use of Knowledge in Society" For the past two decades of my tenure at…
The Fallacy of Tariffs as a Miracle Drug Listening to protectionists tout tariffs as a cure-all solution can make one…
Chinese animation has been making waves in the entertainment industry in recent years, with the success of films like "Ne…
Sign in to your account